Associate Director, Quality Assurance

  • Regular/Permanent
  • USA / Texas
  • In Office

Welcome to Orano Med

Orano Med is at the forefront of research in nuclear medicine and is developing new therapies against cancer. Based on its unique expertise in the production of lead-212 (Pb-212) and radiolabeling technologies, Orano Med is developing innovative radioligand therapies which consist of selectively destroying cancer cells while limiting the impact on surrounding healthy cells.
With a solid portfolio of molecules in development capable of targeting various forms of cancer, and a reliable supply chain for Pb-212, Orano Med aims to become a leader in targeted alpha therapies, in particular for patients with currently unmet medical needs.

Job description

Job Description:

The Associate Director, Quality Assurance supports the Company's short- and long-term goals for maintaining Quality Systems and Compliance. Provides direct oversight for the evaluation, implementation, execution and follow-up on quality systems in support of GMP compliance and release of finished product. This role oversees quality assurance of the manufacturing and packaging processes and procedures, the final review of investigations, and appropriate implementation of corrective actions to prevent recurrence.

This role also provides input into the overall decision-making process pertaining to quality problems, internal and external, that can have far reaching results in terms of rejected batches, stock withdrawals, quarantined goods, revised production and marketing schedules and added manufacturing costs.

Job Duties:

  • Provides daily oversight of the QA teams responsible for supporting all production/processing areas.
  • Develops and monitors appropriate KPI's for batch documentation review, Right First Time (RFT) and support of timely batch release.
  • Responsible for department resource planning, talent development, and budget administration with regards to QA personnel.
  • Directs investigations of product complaints and manufacturing discrepancies for manufactured products and ensures completion of appropriate documentation.
  • Performs review of root-cause analysis and other problem-solving activities to identify effective corrective and preventative actions and appropriate effectiveness measures.
  • Provides QA review and approval of Investigations, CAPAs, SOPs, Change Controls, and protocols/reports.
  • Ensures completeness, accuracy and compliance of all documentation. Coordinates the preparation, review, and approval of the Annual Product Quality Reports and any established metrics / KPIs.
  • Participates in Regulatory/FDA inspections and audits by providing information or expediting/obtaining information required by the inspectors/auditors.
  • Schedules and conducts pre-inspection review of operations and follow-ups where corrective action is required.

Our Full-Time Benefits

  • Competitive compensation 
  • Health, Dental, and Vision insurance – with generous employer contributions 
  • 401(k) with employer matching and contribution amounts 
  • Life insurance and Short- and Long-Term Disability insurance provided by the company  
  • Generous Paid Time Off and holiday schedules 
  • Numerous Training and Development opportunities 
  • and more…   

Ideal qualifications

All candidates must meet the following minimum requirements in order to be considered for this opportunity. Candidates who exceed minimum qualifications may be considered for a higher level position.

  • Bachelor's degree
  • Minimum of 6 years of progressive challenging QA/QC experience, including 3 years as a manager or above, in pharmaceutical or related regulated industry.
  • Sterile injectable and radiopharmaceutical experience a plus.

Associate Director, Quality Assurance

Ref: 2024-18313

Regular/Permanent

1145 E. Northfield Drive, Brownsburg IN

Orano Med LLC

Orano Med is at the forefront of research in nuclear medicine and is developing new therapies against cancer. Based on its unique expertise in the production of lead-212 (Pb-212) and radiolabeling technologies, Orano Med is developing innovative radioligand therapies which consist of selectively destroying cancer cells while limiting the impact on surrounding healthy cells. With a solid portfolio of molecules in development capable of targeting various forms of cancer, and a reliable supply chain for Pb-212, Orano Med aims to become a leader in targeted alpha therapies, in particular for patients with currently unmet medical needs.

Find out more about Orano Med
By clicking “I accept Cookies”, you agree with the cookies use to enhance site navigation, analyze site usage and compile statistics. To get more information, please read our Cookies Policy in the Legal Notice